DeSpenza Jr T, Kiziltug E, Allington G, Barson D, McGee S, OConnor D
Nat Neurosci. 2025; 28(3):536-557.
PMID: 39994410
DOI: 10.1038/s41593-024-01865-3.
Panda V, Mishra B, Nath A, Butti R, Yadav A, Malhotra D
Biomedicines. 2024; 12(7).
PMID: 39062100
PMC: 11274826.
DOI: 10.3390/biomedicines12071527.
Kalnytska O, Qvist P, Kunz S, Conrad T, Willnow T, Schmidt V
iScience. 2024; 27(1):108725.
PMID: 38226160
PMC: 10788290.
DOI: 10.1016/j.isci.2023.108725.
Gerov V, Gerova D, Micheva I, Nikolova M, Pasheva M, Nazifova N
Cancers (Basel). 2023; 15(23).
PMID: 38067265
PMC: 10705189.
DOI: 10.3390/cancers15235562.
Zhu X, Ji J, Han X
J Mol Histol. 2023; 55(1):1-13.
PMID: 37878112
DOI: 10.1007/s10735-023-10169-y.
A novel EGFR inhibitor, HNPMI, regulates apoptosis and oncogenesis by modulating BCL-2/BAX and p53 in colon cancer.
Kandhavelu J, Subramanian K, Naidoo V, Sebastianelli G, Doan P, Konda Mani S
Br J Pharmacol. 2023; 181(1):107-124.
PMID: 37183661
PMC: 10952184.
DOI: 10.1111/bph.16141.
CD44 in Bone Metastasis Development: A Key Player in the Fate Decisions of the Invading Cells?.
Zer N, Ben-Ghedalia-Peled N, Gheber L, Vago R
Clin Exp Metastasis. 2023; 40(2):125-135.
PMID: 37038009
DOI: 10.1007/s10585-023-10203-z.
Osteopontin as a Tumor Marker in Ovarian Cancer.
Rani S, Sehgal A, Kaur J, Pandher D, Punia R
J Midlife Health. 2023; 13(3):200-205.
PMID: 36950209
PMC: 10025823.
DOI: 10.4103/jmh.jmh_52_22.
Tumor: Stroma Interaction and Cancer.
Rogers M, Mi Z, Li N, Wai P, Kuo P
Exp Suppl. 2022; 113:59-87.
PMID: 35165860
DOI: 10.1007/978-3-030-91311-3_2.
Osteopontin Expression in Thyroid Cancer: Deciphering EMT-Related Molecular Mechanisms.
Viana B, Gomes A, Gimba E, Ferreira L
Biomedicines. 2021; 9(10).
PMID: 34680488
PMC: 8533224.
DOI: 10.3390/biomedicines9101372.
Silencing Osteopontin Expression Inhibits Proliferation, Invasion and Induce Altered Protein Expression in Melanoma Cells.
Kiss T, Jambor K, Koroknai V, Szasz I, Bardos H, Mokanszki A
Pathol Oncol Res. 2021; 27:581395.
PMID: 34257527
PMC: 8262222.
DOI: 10.3389/pore.2021.581395.
Osteopontin improves sensitivity to tyrosine kinase inhibitor in lung adenocarcinoma in vitro by promoting epidermal growth factor receptor phosphorylation.
Wang Y, Wang Q, Yu D, Song C, Guo Z, Liu X
J Cancer Res Clin Oncol. 2021; 147(11):3245-3254.
PMID: 34255150
DOI: 10.1007/s00432-021-03731-2.
Serum protein triplet TGF-β1, TIMP-1, and YKL-40 serve as diagnostic and prognostic profile for astrocytoma.
Urbanaviciute R, Zabitaite R, Krisciukaitis A, Deltuva V, Skiriute D
Sci Rep. 2021; 11(1):13100.
PMID: 34162919
PMC: 8222249.
DOI: 10.1038/s41598-021-92328-3.
Melanoma Progression under Obesity: Focus on Adipokines.
Olszanska J, Pietraszek-Gremplewicz K, Nowak D
Cancers (Basel). 2021; 13(9).
PMID: 34068679
PMC: 8126042.
DOI: 10.3390/cancers13092281.
Personalized models of heterogeneous 3D epithelial tumor microenvironments: Ovarian cancer as a model.
Horst E, Bregenzer M, Mehta P, Snyder C, Repetto T, Yang-Hartwich Y
Acta Biomater. 2021; 132:401-420.
PMID: 33940195
PMC: 8969826.
DOI: 10.1016/j.actbio.2021.04.041.
Binding Mode Characterization of Osteopontin on Hydroxyapatite by Solution NMR Spectroscopy.
Holzinger J, Kotisch H, Richter K, Konrat R
Chembiochem. 2021; 22(13):2300-2305.
PMID: 33914399
PMC: 8359842.
DOI: 10.1002/cbic.202100139.
Hyperphosphorylation of Human Osteopontin and Its Impact on Structural Dynamics and Molecular Recognition.
Mateos B, Holzinger J, Conrad-Billroth C, Platzer G, Zerko S, Sealey-Cardona M
Biochemistry. 2021; 60(17):1347-1355.
PMID: 33876640
PMC: 8154273.
DOI: 10.1021/acs.biochem.1c00050.
IS THERE A CLINICAL PATHOLOGICAL CORRELATION OF COLORECTAL ADENOCARCINOMA WITH THE IMMUNOHISTOCHEMICAL EXPRESSION OF OPN AND ABCB5?.
Castoldi D, Malafaia O, Santos-Neto P, Postiglioni T, Vasconcelos C, Bremer F
Arq Bras Cir Dig. 2021; 33(4):e1569.
PMID: 33759959
PMC: 7983527.
DOI: 10.1590/0102-672020200004e1569.
Niche-Mediated Integrin Signaling Supports Steady-State Hematopoiesis in the Spleen.
Mehatre S, Roy I, Biswas A, Prit D, Schouteden S, Huelsken J
J Immunol. 2021; 206(7):1549-1560.
PMID: 33637617
PMC: 7611631.
DOI: 10.4049/jimmunol.2001066.
Automated Assay of a Four-Protein Biomarker Panel for Improved Detection of Ovarian Cancer.
Walker C, Nguyen T, Jessel S, Alvero A, Silasi D, Rutherford T
Cancers (Basel). 2021; 13(2).
PMID: 33477343
PMC: 7830619.
DOI: 10.3390/cancers13020325.